- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06576817
High-intensity Interval Circuit Training in People With Parkinson Disease (PD HIIT)
Comparison of High-intensity Interval Circuit Training With Upper Extremity and Lower Extremity Training Versus Lower Extremity Training Alone in People With Parkinson Disease
The goal of the study is to compare different types of high intensity circuit exercises over an 8-class training series in people with Parkinson disease. The main question it aims to answer is:
-Does including arm and hand exercises with leg exercises improve reaction time, balance, functional measures, gait speed and quality of life? This group will be compared to a group that only does leg exercises. Participants will be asked to participate in 8 high intensity circuit exercise classes.
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Washington
-
Yakima, Washington, United States, 98901
- Pacific Northwest University of Health Sciences
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- diagnosis of Parkinson's disease
- Hoehn and Yahr level of 1 to 3
- ability to walk independently with or without an assistive device
- obtain medical clearance to participate in moderate or vigorous exercise.
Exclusion Criteria:
- diagnosis of any neurological disease other than PD (including but not limited to stroke, dementia, and multiple sclerosis; mild cognitive impairment is not excluded)
- bone instability (non-consolidated fractures, unstable spinal column, severe osteoporosis)
- muscle or ligament tears
- uncontrolled hypertension
- uncontrolled diabetes
- severe cardiovascular disease that impairs walking or exercise
- a major change in medication during the study training period (pre-test to post-test)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Lower extremity and upper extremity exercise
Exercises in the circuit (8 total) will focus on the lower extremity (4) and upper extremity (4)
|
Exercises performed at high intensity effort in the circuit (8 total) will focus on both the lower extremity (4) and upper extremity (4)
|
|
Active Comparator: Lower extremity exercise
Exercises in the circuit (8 total) will focus on the lower extremity (4) alone.
|
All exercises performed at high intensity effort in the circuit (8 total) will focus on the lower extremity alone
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Trail making Test Parts A and B (timed, higher scores mean worse outcome)
Time Frame: 8-10 weeks
|
Cognitive and fine motor skills
|
8-10 weeks
|
|
Activity-specific Balance Confidence Scale (0-100%, higher scores mean better outcome)
Time Frame: 8-10 weeks
|
Balance confidence self-report
|
8-10 weeks
|
|
Timed Up and Go
Time Frame: 8-10 weeks
|
Balance and function
|
8-10 weeks
|
|
10 meter Walk Test
Time Frame: 8-10 weeks
|
Gait Speed
|
8-10 weeks
|
|
6 minute walk test
Time Frame: 8-10 weeks
|
endurance
|
8-10 weeks
|
|
9-hole peg test (timed, higher scores mean worse outcome)
Time Frame: 8-10 weeks
|
fine motor
|
8-10 weeks
|
|
Parkinson's Disease Questionnaire - Short Form (8) (Score 0-32, higher scores mean worse outcome)
Time Frame: 8-10 weeks
|
Quality of Life
|
8-10 weeks
|
Collaborators and Investigators
Investigators
- Principal Investigator: Tiffany B Salido, DPT, PhD, Pacific Northwest University of Health Sciences
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 24-003
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
Bezmialem Vakif UniversityRecruitingParkinson Disease | Parkinson | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseTurkey (Türkiye)
-
CND Life SciencesDigestive Disease Associates of CTRecruitingParkinson Disease | Parkinson | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Neuron23 Inc.Roche Diagnostic Ltd.; Qiagen Manchester LimitedRecruitingParkinson Disease | Parkinson | Idiopathic Parkinson Disease | Parkinson Disease, Idiopathic | Early Parkinson Disease (Early PD)United States, Spain, Israel, Poland, Italy, United Kingdom
-
San Francisco Neurology and Sleep CenterNot yet recruitingPARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Haukeland University HospitalUniversity of Bergen; SPARK NSRecruitingParkinson Disease (PD) | Parkinson s DiseaseNorway
-
CND Life SciencesOregon Health and Science UniversityRecruitingParkinson Disease | Parkinson | Parkinson's Disease and Parkinsonism | PARKINSON DISEASE (Disorder)United States
-
Università degli Studi dell'InsubriaUniversidade Nova de Lisboa; Associazione Parkinson Insubria (AsPI), Section... and other collaboratorsRecruitingParkinson Disease | Parkinson | Parkinson Disease, Idiopathic | PARKINSON DISEASE (Disorder)Italy
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
Duke UniversityMedical University of South Carolina; Massachusetts General Hospital; Mayo Clinic and other collaboratorsNot yet recruitingGut Microbiota | Gut Microbiome | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Prodromal Parkinsons DiseaseUnited States
-
ProgenaBiomeWithdrawnParkinson Disease | Parkinsons Disease With Dementia | Parkinson-Dementia Syndrome | Parkinson Disease 2 | Parkinson Disease 3 | Parkinson Disease 4United States
Clinical Trials on High intensity circuit exercise class - Lower and upper extremity
-
Erol Olcok Corum Training and Research HospitalNot yet recruitingHeart Failure | Implantable Cardioverter Defibrillator (ICD) | Cardiac Resynchronization Therapy Devices
-
Gazi UniversityRecruitingInterstitial Lung DiseaseTurkey
-
McMaster UniversityCompletedMobility Limitation | Fall Injury | Slip and FallCanada
-
Dartmouth-Hitchcock Medical CenterDartmouth CollegeCompletedCompartment Syndromes | Compartment Syndrome of Forearm | Compartment Syndrome of Lower LegUnited States
-
Gazi UniversityRecruitingPrimary ImmunodeficiencyTurkey
-
Riphah International UniversityCompletedDyspnea, ParoxysmalPakistan
-
National Cancer Center, KoreaUnknownGynecologic CancerKorea, Republic of
-
Sivas State HospitalRecruitingMyofascial Pain of Upper Trapezius MuscleTurkey (Türkiye)
-
Duvenciler Anadolu LİsesiCompletedSports Performance | Aerobic Capacity | Neuromuscular Function | Agility | Youth Volleyball | Explosive Strength | Motor Skill DevelopmentTurkey (Türkiye)
-
Alexandria UniversityCompletedLung Diseases | Interstitial Lung Disease | Fibrosis LungEgypt